Effect of Thoracic Mobilization on Lumbar Radiculopathy
Launched by CAIRO UNIVERSITY · Dec 4, 2023
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to see how a specific treatment called thoracic mobilization can help people with a painful condition known as lumbosacral radiculopathy. This condition causes pain in the lower back and legs, often due to nerve issues. The study aims to find out if this treatment can reduce pain, improve daily functioning, and enhance body awareness in patients.
To participate, individuals must be between 30 and 45 years old, have chronic pain in one leg that has lasted for more than 12 weeks, and have a confirmed diagnosis through an MRI. They should also be able to understand instructions and report a certain level of pain. However, people with certain medical conditions, previous surgeries on their spine, or other specific health issues won't be eligible. If you join the trial, you can expect to receive the thoracic mobilization treatment and be monitored for changes in your pain and functionality throughout the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with unilateral chronic lumbosacral radiculopathy at L4- L5 or / and L5-S1 levels confirmed by MRI.
- • 2. The age of patients will be ranged from 30 to 45 years.
- • 3. Duration of pain will be more than 12 weeks.
- • 4. Patients with a positive straight leg raising (SLR) test.
- • 5. Patients with sufficient cognitive abilities that enables them to understand and follow instructions .
- • 6. Patients had to report an average pain level of more than five on the Visual Analogue Scale (VAS) and a lumbar spine range of motion (ROM) of at least 50% of the accepted normal range.
- • 7. Patients with body mass index\< 30kg/m2
- Exclusion Criteria:
- • 1. Cauda equina syndrome.
- • 2. Ankylosing spondylitis, thoracic deformities (pectus carinatum, excavatum), spina bifida, fractures, postoperative spinal conditions, diabetes, inflammatory processes.
- • 3. Previous inner ear infection or vestibular disorder with unresolved balance disturbance, history of head trauma with residual neurological deficits.
- • 4. Spinal tumor.
- • 5. Previous lumbar surgery.
- • 6. Sever musculoskeletal disease.
- • 7. Peripheral mononeuropathies or polyneuropathy.
- • 8. Obesity .
- • 9. Pregnancy.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Nagwa Ibrahim Rehab, Assistant Professor
Study Chair
physical therapy for neuromuscular disorder and its surgery
Ebtesam Mohamed Fahmy, Professor
Study Chair
faculty of medicine
HOSSAM MOHAMMED MOHAMMED, Lecturer
Study Chair
physical therapy for neuromuscular disorder and its surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported